(Q40575826)

21 September 2017

title

Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia (English)

1 reference

21 September 2017

Santolaya ME

1

1 reference

21 September 2017

Alvarez AM

2

1 reference

21 September 2017

Avilés CL

3

1 reference

21 September 2017

Becker A

4

1 reference

21 September 2017

Cofré J

5

1 reference

21 September 2017

Enríquez N

6

1 reference

21 September 2017

O'Ryan M

7

1 reference

21 September 2017

Payá E

8

1 reference

21 September 2017

Salgado C

9

1 reference

21 September 2017

Silva P

10

1 reference

21 September 2017

Tordecilla J

11

1 reference

21 September 2017

Varas M

12

1 reference

21 September 2017

Villarroel M

13

1 reference

21 September 2017

Viviani T

14

1 reference

21 September 2017

Zubieta M

15

1 reference

21 September 2017

language of work or name

English

0 references

publication date

23 August 2002

1 reference

Clinical Infectious Diseases

21 September 2017

published in

1 reference

21 September 2017

volume

35

1 reference

21 September 2017

issue

6

1 reference

21 September 2017

page(s)

678-683

1 reference

Duration of empiric antibiotic therapy in granulocytopenic patients with cancer

21 September 2017

cites work

1 reference

The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies

21 January 2018

1 reference

A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Can

21 January 2018

1 reference

Early discharge of low-risk febrile neutropenic children and adolescents with cancer

21 January 2018

1 reference

Discontinuation of antimicrobial therapy for febrile, neutropenic children with cancer: a prospective study

21 January 2018

1 reference

A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy

21 January 2018

1 reference

Oral administration of cefixime to lower risk febrile neutropenic children with cancer

21 January 2018

1 reference

Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial.

21 January 2018

1 reference

Risk assessment and risk-based therapeutic strategies in febrile neutropenia

21 January 2018

1 reference

Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever

21 January 2018

1 reference

Sepsis syndrome and septic shock in pediatrics: current concepts of terminology, pathophysiology, and management.

21 January 2018

1 reference

The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation

21 January 2018

1 reference

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

21 January 2018

1 reference

Predicting the risk of bacteremia in childen with fever and neutropenia

21 January 2018

1 reference

"Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/342064

1 reference

21 September 2017

1 reference